183 related articles for article (PubMed ID: 37846240)
21. Hematologic Profiles and Correlation Between Absolute Lymphocyte Count and Neutrophil/Lymphocyte Ratio with Markers of Inflammation of COVID-19 in an Indonesian National Referral Hospital.
Sukrisman L; Sinto R; Priantono D
Int J Gen Med; 2021; 14():6919-6924. PubMed ID: 34703296
[TBL] [Abstract][Full Text] [Related]
22. Comorbidities influence the predictive power of hematological markers for mortality in hospitalized COVID-19 patients.
Parthasarathi A; Basavaraja CK; Arunachala S; Chandran S; Venkataraman H; Satheesh A; Mahesh PA
Adv Respir Med; 2022 Jan; ():. PubMed ID: 35099049
[TBL] [Abstract][Full Text] [Related]
23. Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19.
Seyit M; Avci E; Nar R; Senol H; Yilmaz A; Ozen M; Oskay A; Aybek H
Am J Emerg Med; 2021 Feb; 40():110-114. PubMed ID: 33309506
[TBL] [Abstract][Full Text] [Related]
24. Hematological and other Laboratory Parameter Changes in COVID-19 Patients.
Khatib Y; Samele R; Chaudhari J; Khare M; Gupte P; Sable Y; Shah V
J Assoc Physicians India; 2023 Apr; 71(4):11-12. PubMed ID: 37355788
[TBL] [Abstract][Full Text] [Related]
25. Assessing the Impact of Inflammatory Markers and CT Severity Score on Disease Severity of COVID-19 Patients Admitted to ICU at a Tertiary Hospital.
Kurri N; Tyagi B; Singhal E; Gupta N; Agarwal AK; Gupta V; Rai G; Bindra MS
J Assoc Physicians India; 2021 Jun; 69(6):11-12. PubMed ID: 34472783
[TBL] [Abstract][Full Text] [Related]
26. The Relationship of Hematological Parameters and C-reactive Protein (CRP) With Disease Presence, Severity, and Response to Systemic Therapy in Patients With Psoriasis.
Şener G; İnan Yuksel E; Gökdeniz O; Karaman K; Canat HD
Cureus; 2023 Aug; 15(8):e43790. PubMed ID: 37731441
[TBL] [Abstract][Full Text] [Related]
27. The Diagnostic and Predictive Roles of Neutrophil-Lymphocyte Ratio for Severity of Disease in COVID-19 Patients.
Islamoglu MS; Borku-Uysal B; Yavuzer S; Ikitimur H; Seyhan S; Koc S; Cengiz M
Clin Lab; 2021 Dec; 67(12):. PubMed ID: 34910428
[TBL] [Abstract][Full Text] [Related]
28. A Cross-Sectional Comparative Characterization of Hematological Changes in Patients with COVID-19 Infection, Non-COVID Influenza-like Illnesses and Healthy Controls.
Kala M; Ahmad S; Dhebane M; Das K; Raturi M; Tyagi M; Kusum A
Viruses; 2022 Dec; 15(1):. PubMed ID: 36680172
[TBL] [Abstract][Full Text] [Related]
29. An analysis of hematological, coagulation and biochemical markers in COVID-19 disease and their association with clinical severity and mortality: an Indian outlook.
Pujani M; Raychaudhuri S; Singh M; Kaur H; Agarwal S; Jain M; Chandoke RK; Singh K; Sidam D; Chauhan V
Am J Blood Res; 2021; 11(6):580-591. PubMed ID: 35103112
[TBL] [Abstract][Full Text] [Related]
30. Identification of hematological and inflammatory parameters associated with disease severity in hospitalized patients of COVID-19.
Sana A; Avneesh M
J Family Med Prim Care; 2022 Jan; 11(1):260-264. PubMed ID: 35309629
[TBL] [Abstract][Full Text] [Related]
31. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Can Predict the Severity in COVID-19 Patients from Ethiopia: A Retrospective Study.
Ayalew G; Mulugeta B; Haimanot Y; Adane T; Bayleyegn B; Abere A
Int J Gen Med; 2022; 15():7701-7708. PubMed ID: 36238542
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of hematological, coagulation and inflammatory biomarker's role in predicting the severity of disease in patients with COVID-19, admitted in designated COVID-19 hospital of central India.
Lokwani DP; Yadav BS; Bharti S; Gupta V; Toppo N
Indian J Pathol Microbiol; 2021; 64(4):735-740. PubMed ID: 34673594
[TBL] [Abstract][Full Text] [Related]
33. Immunological Biomarkers of COVID-19.
Lei R; Mohan C
Crit Rev Immunol; 2020; 40(6):497-512. PubMed ID: 33900694
[TBL] [Abstract][Full Text] [Related]
34. Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients.
Fathalla LA; Kamal LM; Salaheldin O; Khalil MA; Kamel MM; Fahim HH; Abdel-Moneim YA; Abdulhakim JA; Abdel-Moneim AS; El-Meligui YM
Int J Immunopathol Pharmacol; 2022; 36():3946320221096207. PubMed ID: 35622504
[TBL] [Abstract][Full Text] [Related]
35. Neutrophil-to-Lymphocyte, Lymphocyte-to-Monocyte, and Platelet-to-Lymphocyte Ratios: Prognostic Significance in COVID-19.
Bg S; Gosavi S; Ananda Rao A; Shastry S; Raj SC; Sharma A; Suresh A; Noubade R
Cureus; 2021 Jan; 13(1):e12622. PubMed ID: 33585111
[TBL] [Abstract][Full Text] [Related]
36. Predictive Value of Systemic Immune-Inflammation index and Neutrophil-to-Lymphocyte Ratio in Patients with Severe COVID-19.
Xia W; Tan Y; Hu S; Li C; Jiang T
Clin Appl Thromb Hemost; 2022; 28():10760296221111391. PubMed ID: 35765218
[No Abstract] [Full Text] [Related]
37. A Retrospective Analysis of the Importance of Biochemical and Hematological Parameters for Mortality Prediction in COVID-19 Cases.
Mallappa S; Khatri A; Bn G; Kulkarni P
Cureus; 2022 Oct; 14(10):e30129. PubMed ID: 36381891
[TBL] [Abstract][Full Text] [Related]
38. Neutrophil to lymphocyte ratio and C-reactive protein level as prognostic markers in mild versus severe COVID-19 patients.
Mousavi-Nasab SD; Mardani R; Nasr Azadani H; Zali F; Ahmadi Vasmehjani A; Sabeti S; Alavi Darazam I; Ahmadi N
Gastroenterol Hepatol Bed Bench; 2020; 13(4):361-366. PubMed ID: 33244379
[TBL] [Abstract][Full Text] [Related]
39. [Predictive value of neutrophil/lymphocyte ratio on myocardial injury in severe COVID-19 patients].
Chen Y; Wang KJ; Luo YC; Wang BZ; Zhang MM; Xu YQ; Yang YN; Ma YT
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):572-579. PubMed ID: 32842269
[No Abstract] [Full Text] [Related]
40. Can COVID-19 Mortality be Predicted in the Emergency Room?
Güneysu F; Guner NG; Erdem AF; Durmus E; Durgun Y; Yurumez Y
J Coll Physicians Surg Pak; 2020 Sep; 30(9):928-932. PubMed ID: 33036676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
